In this study we have shown that a novel antagonist of CXCR4, a mutant form of the natural ligand, CXCL12, is capable of blocking the spontaneous metastasis of breast cancer cells from the primary tumor in an orthotopic mouse model of breast cancer. The gene discussed is CXCR4; the disease is breast cancer.